
Keywords: HCC; hepatocellular carcinoma; DEB-TACE; doxorubicin-eluted bead based transarterial chemoembolization; P-CT; perfusion-CT; ALP; arterial liver perfusion; PLP; portal venous perfusion; HPI; hepatic perfusion index; AASLD; American Association for the Stud